XML 34 R20.htm IDEA: XBRL DOCUMENT v3.3.1.900
Stock-Based Compensation
12 Months Ended
Dec. 31, 2015
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Stock-Based Compensation
Stock-Based Compensation
The Company has a stock option and grant plan—the Fourth Amended and Restated 1996 Stock Option and Grant Plan ("Stock Plan"). The Stock Plan, as amended, authorizes the grant of up to 30,400,000 shares of the Company's common stock in the form of: (i) incentive stock options ("ISOs"), (ii) nonqualified stock options, (iii) common stock with or without vesting or other restrictions, (iv) common stock upon the attainment of specified performance goals, (v) restricted stock awards, (vi) the right to receive cash dividends with the holders of the common stock as if the recipient held a specified number of shares of the common stock, (vii) deferred stock awards, (viii) stock appreciation rights and (ix) cash-based awards.
The Stock Plan provides that: (i) the exercise price of an ISO must be no less than the fair value of the stock at the date of grant and (ii) the exercise price of an ISO held by an optionee who possesses more than 10% of the total combined voting power of all classes of stock must be no less than 110% of the fair market value of the stock at the time of grant. The Compensation Committee of the Board of Directors has the authority to set expiration dates no later than ten years from the date of grant (or five years for an optionee who meets the 10% criterion), payment terms, and other provisions for each grant. The majority of options granted have a four-year vesting period. Shares associated with unexercised options or reacquired shares of common stock (except those shares withheld as a result of tax withholding or net issuance) become available for option grants and common stock issuances under the Stock Plan. The Compensation Committee of the Board of Directors may, at its sole discretion, accelerate or extend the date or dates on which all or any particular award or awards granted under the Stock Plan may vest or be exercised.
In the event of a "sale event" as defined in the Stock Plan, all outstanding awards will be assumed or continued by the successor entity, with appropriate adjustment in the awards to reflect the transaction. In such event, except as the Compensation Committee may otherwise specify with respect to particular awards in the award agreements, if the service relationship of the holder of an award is terminated without cause within 18 months after the sale event, then all awards held by such holder will become fully vested and exercisable at that time. If there is a sale event in which the successor entity refuses to assume or continue outstanding awards, then subject to the consummation of the sale event, all awards with time-based vesting conditions will become fully vested and exercisable at the effective time of the sale event and all awards with performance-based vesting conditions may become vested and exercisable in accordance with the award agreements at the discretion of the Compensation Committee. If awards are not assumed or continued after a sale event, then all such awards will terminate at the time of the sale event. In the event of the termination of stock options or stock appreciation rights in connection with a sale event, the Compensation Committee may either make or provide for a cash payment to the holders of such awards equal to the difference between the per share transaction consideration and the exercise price of such awards or permit each holder to have at least a 15-day period to exercise such awards prior to their termination.
The Company currently issues shares related to exercised stock options or vested awards from its existing pool of treasury shares and has no specific policy to repurchase treasury shares as stock options are exercised or as awards vest. If the treasury pool is depleted, the Company will issue new shares.
Total stock-based compensation expense recognized for the years ended December 31, 2015, 2014 and 2013 is as follows:
 
 
Year Ended December 31,
(in thousands, except per share amounts)
 
2015
 
2014
 
2013
Cost of sales:
 
 
 
 
 
 
Software licenses
 
$
745

 
$
1,776

 
$
1,349

Maintenance and service
 
1,868

 
2,035

 
2,293

Operating expenses:
 
 
 
 
 
 
Selling, general and administrative
 
17,153

 
17,073

 
16,847

Research and development
 
14,185

 
15,977

 
14,809

Stock-based compensation expense before taxes
 
33,951

 
36,861

 
35,298

Related income tax benefits
 
(11,656
)
 
(10,927
)
 
(11,096
)
Stock-based compensation expense, net of taxes
 
$
22,295

 
$
25,934

 
$
24,202

Net impact on earnings per share:
 
 
 
 
 
 
Basic earnings per share
 
$
(0.25
)
 
$
(0.28
)
 
$
(0.26
)
Diluted earnings per share
 
$
(0.24
)
 
$
(0.28
)
 
$
(0.25
)

Information regarding stock option transactions is summarized below:
 
 
Year Ended December 31,
 
 
2015
 
2014
 
2013
(options in thousands)
 
Options
 
Weighted-
Average
Exercise
Price
 
Options
 
Weighted-
Average
Exercise
Price
 
Options
 
Weighted-
Average
Exercise
Price
Outstanding, beginning of year
 
4,932

 
$
48.76

 
6,166

 
$
44.77

 
7,122

 
$
42.85

Granted
 
57

 
$
88.10

 
150

 
$
81.09

 
103

 
$
81.87

Issued pursuant to acquisitions
 
8

 
$
12.26

 
21

 
$
23.26

 

 
$

Exercised
 
(975
)
 
$
40.52

 
(1,266
)
 
$
31.36

 
(993
)
 
$
34.26

Forfeited
 
(36
)
 
$
70.15

 
(139
)
 
$
61.11

 
(66
)
 
$
53.75

Outstanding, end of year
 
3,986

 
$
51.07

 
4,932

 
$
48.76

 
6,166

 
$
44.77

Vested and Exercisable, end of year
 
3,539

 
$
48.29

 
3,958

 
$
44.22

 
4,351

 
$
38.18

 
 
 
2015
 
2014
 
2013
Weighted-Average Remaining Contractual Term (in years)
 
 
 
 
 
 
Outstanding
 
4.85

 
5.53

 
5.99

Vested and Exercisable
 
4.53

 
5.00

 
5.13

Aggregate Intrinsic Value (in thousands)
 
 
 
 
 
 
Outstanding
 
$
165,131

 
$
163,932

 
$
261,601

Vested and Exercisable
 
$
156,487

 
$
149,536

 
$
213,304


Historical and future expected forfeitures have not been significant and, as a result, the outstanding option amounts reflected in the tables above approximate the options expected to vest.
The fair value of each option grant is estimated on the date of grant, or date of acquisition for options issued in a business combination, using the Black-Scholes option pricing model, which was developed for use in estimating the fair value of traded options that have no vesting restrictions and are fully transferable. The Company's options have characteristics significantly different from those of traded options, and changes in input assumptions can materially affect the fair value estimates. The interest rates used were determined by using the five-year Treasury Note yield at the date of grant or date of acquisition for options issued in a business combination. The volatility was determined based on the historic volatility of the Company's stock during the preceding six years for 2015, 2014 and 2013.
The table below presents the weighted average input assumptions used and resulting fair values for options granted or issued in business combinations during each respective year:
 
 
Year Ended December 31,
 
 
2015
 
2014
 
2013
Risk-free interest rate
 
1.18% to 1.65%
 
1.49% to 1.76%
 
0.68% to 1.48%
Expected dividend yield
 
—%
 
—%
 
—%
Expected volatility
 
25%
 
35%
 
37%
Expected term
 
5.6 years
 
5.7 years
 
5.8 years
Weighted-average fair value per share
 
$30.83
 
$32.26
 
$29.85

As stock-based compensation expense recognized in the consolidated statements of income is based on awards ultimately expected to vest, it must be reduced for estimated forfeitures. Forfeitures are estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates. The effect of pre-vesting forfeitures on the Company's recorded expense has historically been negligible due to the relatively low turnover of stock option holders.
The Company's determination of fair value of share-based payment awards on the date of grant using an option pricing model is affected by the Company's stock price as well as assumptions regarding a number of variables. The total estimated grant-date fair values of stock options that vested during the years ended December 31, 2015, 2014 and 2013 were $12.3 million, $19.5 million and $24.7 million, respectively. As of December 31, 2015, total unrecognized estimated compensation cost related to unvested stock options granted prior to that date was $10.1 million, which is expected to be recognized over a weighted-average period of 1.4 years. The total intrinsic values of stock options exercised during the years ended December 31, 2015, 2014 and 2013 were $47.1 million, $60.6 million and $45.2 million, respectively. As of December 31, 2015, 0.4 million unvested options with an aggregate intrinsic value of $9.2 million are expected to vest and have a weighted-average exercise price of $73.13 and a weighted-average remaining contractual term of 7.4 years. The Company recorded cash received from the exercise of stock options of $39.5 million and tax benefits related to all stock activity of $17.7 million for the year ended December 31, 2015.
Information regarding stock options outstanding as of December 31, 2015 is summarized below:
(options in thousands)
 
Options Outstanding
 
Options Exercisable
Range of Exercise Prices
 
Options
 
Weighted-
Average
Remaining
Contractual
Life (years)
 
Weighted-
Average
Exercise
Price
 
Options
 
Weighted-
Average
Exercise
Price
$5.91 - $38.75
 
1,030

 
2.49
 
$
29.68

 
1,019

 
$
29.81

$38.86 - $48.97
 
1,077

 
4.27
 
$
45.39

 
1,077

 
$
45.39

$51.52 - $65.72
 
802

 
5.64
 
$
58.68

 
794

 
$
58.64

$67.34 - $94.15
 
1,077

 
7.08
 
$
71.55

 
649

 
$
69.43


Under the terms of the ANSYS, Inc. Long-Term Incentive Plan, the Company issues various restricted stock awards, which may have a market condition, an operating performance condition or a service condition, or any combination of the three. The Company granted 34,450, 47,000 and 94,300 performance-based restricted stock units with a market condition in 2015, 2014 and 2013, respectively. The percentage of the award that vests is based on the Company's performance as measured by total shareholder return relative to the median percentage appreciation of a specified stock index over the measurement period, subject to each participant's continued employment with the Company through the conclusion of the measurement period. The measurement periods for the restricted stock units granted pursuant to the Long-Term Incentive Plan are one-, two- and three-year periods beginning January 1 of the year of the grant. Each restricted stock unit relates to one share of the Company's common stock. The weighted-average fair value of each restricted stock unit granted in 2015, 2014 and 2013 was estimated on the grant date to be $81.61, $65.94 and $50.05, respectively. The fair value of the restricted stock units was estimated using a Monte Carlo simulation model. The determination of the fair value of the awards was affected by the grant date and a number of variables, each of which has been identified in the chart below. Share-based compensation expense based on the fair value of the award is being recorded from the grant date through the conclusion of the three-year measurement period. Total compensation expense associated with the market condition awards recorded for the years ended December 31, 2015, 2014 and 2013 was $3.1 million, $2.5 million and $3.6 million, respectively.
 
Year Ended December 31,
Assumptions used in Monte Carlo lattice pricing model
2015
 
2014
 
2013
Risk-free interest rate
1.1%
 
0.7%
 
0.4%
Expected dividend yield
—%
 
—%
 
—%
Expected volatility—ANSYS stock price
23%
 
25%
 
25%
Expected volatility—NASDAQ Composite Index
14%
 
15%
 
20%
Expected term
2.8 years
 
2.8 years
 
2.8 years
Correlation factor
0.60
 
0.70
 
0.70

During 2015, the Company issued 51,795 restricted stock awards with vesting conditions based on defined operating metrics and a weighted-average grant-date fair value of $86.38. During 2014, the Company issued 20,667 restricted stock awards with vesting conditions based on defined operating metrics and a weighted-average grant-date fair value of $81.52. The grant-date fair value of the awards is being recorded from the grant date through the conclusion of the measurement period associated with each operating metric based on management's estimates concerning the probability of vesting. Total compensation expense associated with these awards recorded for the years ended December 31, 2015 and 2014 was $0.4 million and $0.1 million, respectively.
In addition, in 2015 and 2014, the Company granted restricted stock units of 344,500 and 364,150, respectively, that will vest over a four-year period with a weighted-average grant-date fair value of $86.34 and $82.13, respectively. During 2015, 85,713 shares vested and were released. As of December 31, 2015 and 2014, 571,462 and 344,750 units were outstanding, respectively. Total compensation expense is being recorded over the four-year service period and was $12.5 million and $5.8 million for the years ended December 31, 2015 and 2014, respectively.
In conjunction with a 2015 acquisition, ANSYS issued 68,451 shares of replacement restricted stock with a weighted-average grant-date fair value of $90.48. Of the $6.2 million grant-date fair value, $3.5 million, related to partially vested awards, was recorded as non-cash purchase price consideration. The remaining fair value will be recognized as stock compensation expense through the conclusion of the service period. During the year ended December 31, 2015, the Company recorded $0.6 million of stock compensation expense related to these awards.
In conjunction with a 2011 acquisition, the Company granted performance-based restricted stock awards. Vesting was determined based on the achievements of certain revenue and operating income targets of the entity post-acquisition. Total compensation expense associated with the awards recorded for the years ended December 31, 2014 and 2013 was $4.7 million and $3.8 million, respectively.
The Company has granted deferred stock units to non-affiliate Independent Directors, which are rights to receive shares of common stock upon termination of service as a Director. The deferred stock units were issued quarterly in arrears and vested immediately upon grant. As of December 31, 2015, 189,099 deferred stock units have been earned with the underlying shares remaining unissued until the service termination of the respective Director owners. Of this amount, 43,134 units were earned during the year ended December 31, 2015. Total compensation expense associated with the awards recorded for the years ended December 31, 2015, 2014 and 2013, was $4.0 million, $3.5 million and $2.5 million, respectively.